Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
276 studies found for:    Hair Diseases
Show Display Options
Rank Status Study
1 Recruiting AGA Biocellular Stem/Stromal Hair Regenerative Study
Condition: Hair Disease
Interventions: Procedure: Intradermal Injection in hair loss;   Procedure: Platelet Rich Plasma;   Procedure: Adipose Derived Stem/Stromal Cells;   Procedure: Stem/Stromal Cellular Isolation (Digestive);   Procedure: MatriStem Matrix (ACell) - Current Standard of Care;   Procedure: HD-PRP (High Density Platelet Rich Plasma);   Procedure: Emulsified AD-tSVF;   Procedure: Emulsified AD-cSVF
2 Recruiting EValuation of the Impact of a TOpical Lotion on Permanent Chemotherapy Induced Hair Disorders in Cancer Survivors
Condition: Alopecia
Interventions: Other: CG428;   Other: Placebo
3 Not yet recruiting Point-of-Care Adipose-derived Cells for Hair Growth
Condition: Androgenetic Alopecia
Interventions: Procedure: Stromal Vascular Fraction Cells (SVF Cells) Injection;   Procedure: Liposuction;   Other: Hair Measurements
4 Completed Low Fluence 1064nm Laser Hair Reduction for Pseudofolliculitis Barbae in Skin Types IV, V, VI
Condition: Pseudofolliculitis Barbae
Intervention: Procedure: 1064nm Nd:YAG laser at 12 J/cm2, 20 ms and 10mm spot size.
5 Completed Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae
Condition: Pseudofolliculitis Barbae
Intervention: Drug: 15% Eflornithine Hdyrochloride
6 Completed
Has Results
Copper Histidine Therapy for Menkes Diseases
Condition: Kinky Hair Syndrome
Intervention: Drug: Copper Histidine
7 Recruiting Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency
Conditions: Menkes Disease;   Occipital Horn Syndrome
Intervention: Drug: Copper Histidine
8 Completed Effect of PRP on the Therapy for Hair Growth
Condition: Hair Loss/Baldness
Intervention: Other: hair loss, baldness (patient's own platelet-rich plasma)
9 Completed Androgenetic Alopecia in Fabry Disease
Condition: Fabry Disease
Intervention:
10 Completed Study of Wound Packing After Superficial Skin Abscess Drainage
Conditions: Abscess;   Skin Diseases, Infectious;   Boils;   Furuncle;   Carbuncle;   Folliculitis;   Cellulitis;   Wounds
Interventions: Procedure: Wound packing;   Procedure: NoPacking
11 Completed Optical Clearing of the Skin in Conjunction With Laser Treatments
Conditions: Port Wine Stain;   Nevus of Ota;   Tattoos;   Scars;   Acne;   Hypertrichosis;   Sebaceous Gland Diseases
Intervention: Device: Optical Clearing
12 Completed Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix
Conditions: Keloid;   Scleroderma, Localized;   Acne Keloidalis;   Scars;   Granuloma Annulare
Intervention: Procedure: UVB Irradiation
13 Active, not recruiting Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer
Conditions: Alopecia;   Anxiety;   Breast Carcinoma;   Cognitive Side Effects of Cancer Therapy;   Colorectal Carcinoma;   Depression;   Fatigue;   Lung Carcinoma;   Nausea and Vomiting;   Pain;   Psychological Impact of Cancer;   Sleep Disorder;   Weight Change
Interventions: Procedure: Quality-of-Life Assessment;   Procedure: Yoga
14 Terminated Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions
Conditions: Atopic Dermatitis;   Psoriasis;   Alopecia;   Mycosis Fungoides;   Urticaria;   Dermatoses;   Stretch Marks
Interventions: Procedure: UVA1 Irradiation;   Procedure: UVB Irradiation
15 Terminated UVA1 Light for Scleroderma and Similar Conditions
Conditions: Keloid;   Scleroderma;   Scars;   Granuloma Annulare;   Acne Keloidalis Nuchae
Intervention: Device: German manufactured UVA1 emitting light system
16 Completed Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions
Conditions: Prostate Cancer;   Hirsutism
Interventions: Drug: Bicalutamide 50 mg Film-Coated Tablets (Sandoz Inc., USA);   Drug: Bicalutamide 50 mg Film-Coated Tablets (Casodex) (Astrazeneca Pharmaceutical LP, USA)
17 Completed Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions
Conditions: Prostate Cancer;   Hirsutism
Interventions: Drug: Bicalutamide 50 mg Film-Coated Tablets (Casodex) (Astrazeneca Pharmaceutical LP, USA);   Drug: Bicalutamide 50 mg Film-Coated Tablets (Sandoz Inc., USA)
18 Active, not recruiting Minoxidil Response Testing in Females With Female Pattern Hair Loss
Conditions: Alopecia;   Female Pattern Hair Loss
Intervention: Drug: 5% minoxidil topical foam
19 Completed To Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning Hair
Condition: Hair Thinning
Intervention: Dietary Supplement: Viviscal Oral Supplement Tablets
20 Completed Efficacy of the New Viviscal Professional Strength Oral Supplement in Females With Thinning Hair
Condition: Hair Thinning
Interventions: Dietary Supplement: New Viviscal Professional Supplement;   Dietary Supplement: Placebo tablets

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years